Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Investing

New Study Shows Decriminalization Did Not Cause Spike in Oregon’s Overdose Deaths—the Fentanyl Wave Caused It

by September 6, 2024
September 6, 2024
New Study Shows Decriminalization Did Not Cause Spike in Oregon’s Overdose Deaths—the Fentanyl Wave Caused It

Jeffrey A. Singer

In a blog post earlier this year, I lamented the decision by Oregon lawmakers to roll back Measure 110, a ballot proposition that Oregon voters passed in November 2020 decriminalizing drug use and possession while expanding access to harm reduction and addiction treatment services.

Measure 110 went into effect in February 2021, when COVID-19 pandemic policies and bureaucratic delays blocked harm reduction and treatment services. Complicating matters further, fentanyl, which had been making its way in an east-to-west wave across the country, arrived in the Pacific Northwest around 2019–2020, causing a spike in opioid-related overdoses similar to the spikes seen in every other region when fentanyl entered the drug supply. ( By 2018, almost 90 percent of overdose deaths involving fentanyl and its analogs occurred in 28 states east of the Mississippi River.) These factors combined to create a “perfect storm,” leading Oregon policymakers to believe Measure 110 was responsible for the increase in overdose deaths.

With the law in effect only two years, and with the expansion of harm reduction and treatment services begun only eight months earlier, Oregon lawmakers re-criminalized drug possession. Pundits supporting drug prohibition were quick to point to Oregon as an argument against decriminalization.

Today, researchers from Brown University and RTI International published new research in the Journal of the American Medical Association (JAMA) that analyzed the association between fatal overdose and the enactment of Measure 110. The researchers conducted a cohort study using a “matrix completion synthetic control method.” The 48 states and the District of Columbia that had not decriminalized drugs served as the control. The researchers assessed the prevalence of fentanyl in unregulated drug markets by analyzing the percentage of state-level drug samples reported to the National Forensic Laboratory Information System and identified as fentanyl or its analog. They obtained mortality data from January 1, 2008, to December 31, 2022, from the Centers for Disease Control and Prevention. The primary outcome they assessed was fatal overdose rates per half-year. They used a changepoint analysis—a statistical technique that detects points in a data series where the properties or underlying patterns change—to determine when the fentanyl wave hit each state. Their findings:

After adjusting for the spread of fentanyl as a confounder, the effect size changed signs (estimate [SE], −0.51 [0.61]; P = .41) and there was no longer an association between decriminalization and overdose mortality in Oregon.

The researchers’ conclusion:

In this cohort study of fatal drug overdose and the spread of fentanyl through Oregon’s unregulated drug market, no association between M110 and fatal overdose rates was observed. Future evaluations of the health effects of drug policies should account for changes in the composition of unregulated drug markets.

There is now empirical evidence showing decriminalization critics and Oregon lawmakers too quickly abandoned Oregon’s “experiment” with decriminalization combined with increased access to harm reduction and treatment. Will the critics examine this new evidence?

Alas, it may be too late. All the bad publicity hoisted unjustly on Oregon’s short-lived attempt at drug policy reform has set back similar reforms in other parts of the country.

0
FacebookTwitterGoogle +Pinterest
previous post
Harris failing to cobble together Biden’s winning 2020 coalition: analysis
next post
Friday Feature: Classic Learning Test

You may also like

The Place of Family and Religion in Civil...

April 4, 2025

Still Out of Reach: Why Effective Opioid Treatment...

April 15, 2025

Prohibition Kills

July 10, 2024

12 Graphs on Why Maduro Could Only “Win”...

July 30, 2024

David Boaz and the Ideas of Liberty

June 7, 2024

High Costs of Low-Income Housing

December 18, 2023

Work Requirements in SNAP

April 24, 2023

To Eliminate Underground Markets, Tax and Regulate Less

May 22, 2024

Introducing the CBDC Tracker, a Project of the...

November 14, 2023

Toughening Laws on Noncitizen Voting: Evaluating the SAVE...

August 9, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Trump and Rubio secure Rwanda-Congo peace treaty amid Pakistan’s Nobel Prize nomination

      June 21, 2025
    • State Department says it has provided guidance to more than 25,000 people in Israel, West Bank and Iran

      June 21, 2025
    • Several provisions fail to pass muster with Senate rules in ‘big, beautiful bill’

      June 21, 2025
    • ‘She’s wrong’: Trump says Tulsi Gabbard incorrect about Iran not having nuclear weapon capabilities

      June 20, 2025
    • WATCH: Dem senators blame Trump for Iran crisis as GOP urges him to stand firm with Israel

      June 20, 2025
    • European diplomats urge Iran to continue US nuclear talks in first face-to-face since strikes started

      June 20, 2025

    Categories

    • Business (8,275)
    • Investing (2,057)
    • Politics (15,724)
    • Stocks (3,158)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved